Target intelligence / Profile preview

Cuproenzyme

Molecular classification
Enzyme, Oxidase, Monooxygenase, Dioxygenase, Other
01

Overview

Cuproenzymes are a broad group of enzymes that require copper as an essential cofactor in their catalytic site; they are not a specific single target but encompass multiple distinct enzymes, each with a unique protein structure and biological role. The most prominent cuproenzymes include cytochrome c oxidase (energy production in mitochondria), lysyl oxidase (cross-linking of connective tissue proteins), superoxide dismutase (antioxidant defense), ceruloplasmin (iron metabolism), tyrosinase (melanin synthesis), dopamine β-hydroxylase (neurotransmitter synthesis), and laccase (phenolic oxidation)[3][5][6][9][2][1]. These enzymes are vital for processes like cellular respiration, iron homeostasis, detoxification of reactive oxygen species, synthesis of neurotransmitters and connective tissues, and pigment formation. While some diseases and drugs target the copper requirement of these enzymes (notably in Wilson's Disease or in experimental cancer treatments via cuproptosis), "cuproenzyme" itself is too generic to denote a single druggable target[4][9][3]. The group contains diverse protein families (including oxidases, monooxygenases, and dioxygenases[1][5]), and dysfunction in individual cuproenzymes can contribute to a range of human diseases, especially those involving copper metabolism and homeostasis[3][7][9].

Other names
Copper enzymeCopper-dependent enzymeCopper-containing enzymeCuproprotein
02

Mechanism of action

Copper chelation (inhibition of copper-dependent enzymes), Metal-based anticancer therapies by induction of copper-dependent cell death (cuproptosis), Enzyme inhibition

03

Biological functions

Energy productionAntioxidant defenseConnective tissue formationIron metabolismNeurotransmitter synthesisCell signalingOxygen transportOther
04

Disease associations

Cardiovascular diseaseNeurodegenerative diseaseCancerHereditary metabolic disordersOther
05

Safety considerations

Systemic copper deficiency (anemia, connective tissue disorder, neurologic issues)Excess copper toxicity (liver, kidney, neurologic injury)Narrow therapeutic index for chelatorsOff-target inhibition of essential cuproenzymes
06

Interacting drugs

Penicillamine

6 more in the full profile.

07

Biomarkers

Serum ceruloplasminActivity of specific cuproenzymes (e.g., superoxide dismutase, cytochrome c oxidase)Copper levels in blood/urine

Beyond the preview

Go deeper on Cuproenzyme.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cuproenzyme.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call